Carcinogenicity Reduction
Carcinogenicity Reduction is a toxicological intervention strategy that specifically diminishes the potential of substances to induce cancer through mechanisms such as mutagenicity suppression, metabolic detoxification, or inhibition of tumor promotion pathways.
83
Publications
4.2K
Citations
323
Authors
110
Institutions
Publications per year
2017–2026
6
Parents
83
M. Eileen Dolan, Robert C. Moschel, Anthony E. Pegg · Proceedings of the National Academy of Sciences · 1990 · 461 citations
Medicine, Oncology, Pharmacology +9
Rationale and strategies for chemoprevention of cancer in humans.
John S. Bertram, Laurence N. Kolonel, Frank L. Meyskens · PubMed · 1987 · 363 citations
Medicine, Oncology, Pharmacology +13
Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene
J. Abiodun Elegbede, Charles E. Elson, Asaf A. Qureshi et al. · Carcinogenesis · 1984 · 170 citations
Medicine, Oncology, Pharmacology +14
1–5 of 83
323
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 323
110
University of Wisconsin–Madison
Madison, United States
3 h-index
10 publications
904 citations
Institute for Cancer Prevention
Valhalla, United States
3 h-index
7 publications
544 citations
National Institute of Health Sciences
Tokyo, Japan
3 h-index
12 publications
288 citations
The Ohio State University
Columbus, United States
3 h-index
9 publications
439 citations
University of Rajasthan
Jaipur, India
3 h-index
8 publications
343 citations

University of Minnesota
Minneapolis, United States
2 h-index
7 publications
367 citations

University of Georgia
Athens, United States
2 h-index
8 publications
162 citations
National Cancer Research Institute
London, United Kingdom
2 h-index
4 publications
43 citations
1–8 of 110
Repository · 19 publications · 994 citations
13
h-index
7 publications · 629 citations
7
h-index
6 publications · 404 citations
6
h-index
2 publications · 67 citations
2
h-index
2 publications · 87 citations
2
h-index
1–5